Research ArticleOriginal Article

The Mid-Long Term Outcome of Breast-Conserving Patients with Different Ages

Huiming Zhang, Xiang Wang and Baoning Zhang
Clinical Oncology and Cancer Research August 2009, 6 (4) 250-255; DOI: https://doi.org/10.1007/s11805-009-0250-4

References

  1. ↵
    1. Veronesi U,
    2. Cascinelli N,
    3. Mariani L, et al.
    Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-1232.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Fisher B,
    2. Anderson S,
    3. Redmond CK, et al.
    Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333: 1456-1461.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Blichert-Toft M,
    2. Nielsen M,
    3. Düring M, et al.
    Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follwup of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008; 47: 672-681.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Kothari AS,
    2. Fentiman IS.
    Breast cancer in young women. Int J Clin Pract 2002; 56: 184-187.
    OpenUrlPubMed
  5. ↵
    1. Kwong A,
    2. Cheung P,
    3. Chan S, et al.
    Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg 2008; 32: 2554-2561.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Fisher B,
    2. Anderson S,
    3. Bryant J, et al.
    Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Tiezzi DG,
    2. Andrade JM,
    3. Marana HR, et al.
    Breast conserving surgery after neoadjuvant therapy for large primary breast cancer. Eur J Surg Oncol 2008; 34: 863-867.
    OpenUrlPubMed
    1. Inaji H,
    2. Komoike Y,
    3. Motomura K, et al.
    Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer. Breast Cancer 2002; 9: 20-25.
    OpenUrlPubMed
  9. ↵
    1. Cance WG,
    2. Carey LA,
    3. Calvo BF, et al.
    Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 2002; 236: 295-303.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Han W,
    2. Kim SW,
    3. Park IA, et al.
    Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 2004; 4: 82.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Figueiredo JC,
    2. Ennis M,
    3. Knight JA, et al.
    Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat 2007; 105: 69-80.
    OpenUrlCrossRefPubMed
  12. ↵
    1. El Saghir NS,
    2. Seoud M,
    3. Khalil MK, et al.
    Effects of young age at presentation on survival in breast cancer. BMC Cancer 2006; 6: 194.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Zhou P,
    2. Recht A.
    Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 2004; 101: 1264-1274.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Michelle K Nottage,
    2. Karen A Kopciuk,
    3. Anjela Tzontcheva, et al.
    Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study. Breast Cancer Res 2006; 8: R44.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Beenken SW,
    2. Urist MM,
    3. Zhang Y, et al.
    Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg 2003; 237: 732-739.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Kroman N,
    2. Holtveg H,
    3. Wohlfahrt J, et al.
    Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 2004; 100: 688-693.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Nguyen PL,
    2. Taghian AG,
    3. Katz MS, et al.
    Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008; 26: 2373-2378.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Zhou P,
    2. Gautam S,
    3. Recht A.
    Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat 2007; 101: 51-57.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Neri A,
    2. Marrelli D,
    3. Rossi S, et al.
    Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence. World J Surg 2007; 31: 36-45.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Elkhuizen PH,
    2. van Slooten HJ,
    3. Clahsen PC, et al.
    High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol 2000; 18: 1075-1083.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords